Last reviewed · How we verify

NCT04515056

Characterization of New Human Models of Non-histaminergic Itch

Completed NA Last updated 9 July 2021
What this trial tests

NA trial testing Papain 10 µg in Papain in 20 participants. Completed in 1 June 2021.

Timeline
1 September 2020
Primary endpoint
1 June 2021
1 June 2021

Quick facts

Lead sponsorAalborg University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposebasic science
Enrollment20
Start date1 September 2020
Primary completion1 June 2021
Estimated completion1 June 2021
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Papain or Itch. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this experiment the investigators would like to test a new new human itch model based on papain, and to characterize the sensory quality and temporary aspects of papain skin prick test (SPT) in comparison to the inactivated-cowhage delivery system.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Physiological functions and pharmacological targeting of transient receptor potential channels.
    Chubanov V, Grimm C, Hill K, Schaefer M, et al · · 2025 · PMID 41118703 · DOI 10.1016/j.pharmr.2025.100089

Verify or expand the search:

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04515056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing